Latest News
Untap, a next generation portfolio management solution for private capital markets to manage investments, strategies, ESG and Value Creation, has been accepted into Newchip’s renowned global accelerator programme.
Designed to provide all the skills and tools seed-stage founders need to rapidly fund, build and scale their companies, past accelerator cohorts averaged more than 17.5 times the average funding amount. The equity-free, fully digital accelerator has helped over 1,000 founders from 35 countries raise over USD300 million in funding.
“Newchip evaluates a vast and diverse number of companies from across the globe, selecting only a small percentage to be part of
Robert Bosch Venture Capital, the corporate venture capital company of the Bosch Group, has completed an investment in Variantyx Inc.
Variantyx and Robert-Bosch Hospital join forces to improve personalised oncology treatment with plans to incorporate the Variantyx solution into the oncology treatment process. Variantyx provides clinicians with advanced diagnostics and personalised treatment recommendations for oncology patients’ based on their unique genetic makeup.
“For several years the Robert-Bosch Hospital, the Robert Bosch Stiftung, and the Bosch Group have been joining forces to fight cancer,” says Dr Ingo Ramesohl, Managing Director of Robert Bosch Venture Capital. “Variantyx’s solution is outstanding. Together, Variantyx
Gentronix, the UK-based contract research organisation (CRO) in the field of genetic toxicology, has raised GBP700,000 in a funding round led by existing investor Mercia to support its continued growth.
The latest round, which includes a number of private investors, follows Gentronix’s recent acquisition of the Big Blue® transgenic mutation assay from Merck KGaA. It will be used to fund the onboarding and delivery of the new service and expand the company’s genetic, skin and ocular toxicology services.
Gentronix provides companies developing new chemical or pharmaceutical products with toxicology tests required by regulators to show that they are safe
Ferreira de Sá, a company backed by private equity firm Sherpa Capital, has acquired 100 per cent of the shares of Desistart, a Portuguese company dedicated to the production and marketing of carpets for the luxury segment, from its founders.
Founded by Henrique Ferreira and Rosa de Lurdes de Sousa Marques, Desistart has experienced fast growth in recent years thanks to the quality of its products and the entry into new markets, which has led it to double its sales since 2017, up to EUR3 million per year.
With approximately 45 employees, Desistart currently generates more than 80 per
Graphite Capital, a UK mid-market private equity specialist, has acquired Opus Talent Solutions, a global recruitment business specialising in the technology and renewable energy markets, backing a management buy-out from the company’s founder.
Headquartered in Bristol, Opus has more than 1,000 clients in over 50 countries. It employs 300 staff across eight offices spanning the UK (Bristol, Manchester and London), the Netherlands (Amsterdam), Australia (Sydney) and the US (New York, Tampa and Dallas).
Opus has three complementary trading brands, all focused on high-growth niche markets, generating a combined net fee income (NFI) of approximately GBP30 million. The largest, accounting
WSO2, a specialist in digital transformation technology, has closed USD90 million in financing from client vehicles advised by Goldman Sachs Asset Management Private Credit (Goldman Sachs).
The flexible capital solution will be used to accelerate WSO2’s worldwide business expansion, drive growth of the company’s global partner network, and support rollout of its next-generation, cloud-native solutions for securely delivering APIs, applications, and digital services. The new solutions, powered by Ballerina, will offer a seamless blend of low code and pro code experience for enterprises and deliver the power of DevOps and modern SDLC practices including integrated reuse within the organisation and
Grosvenor’s Wheatsheaf Group, an international investor in Food & AgTech, is introducing a new partnership model to lead the organisation through its next phase of growth and development – this will also see Wheatsheaf being renamed as Grosvenor Food & AgTech from January 2022.
Current Executive Directors Anthony James, Katrin Burt, Monty Bayer, Peter Kristensen and Stephan Dolezalek will lead the business as managing partners, taking decisions collectively in the best long-term interests of the business and its stakeholders – working with portfolio companies to support their growth and development, scaling up their reach and impact, while pursuing new investment
MCF Corporate Finance, a corporate finance advisory firm, has appointed Atul Monga, CFA, as Partner in their technology practice in London.
MCF specialises in cross-border and domestic M&A transactions and capitalraisings in Europe, across five core verticals: Business Services, Industrials, Consumer, Materials and Technology. The firm’s c60 professionals operate across offices in London, Helsinki, Stockholm, and Hamburg.
Since its establishment, the firm has advised on over 500 transactions, across multiple industry sectors and countries. The team continue to work in close partnership with DA Davidson, the growing North American investment bank.
Atul joins MCF’s growing technology team having
One Rock Capital Partners (One Rock) has added Adam Kuritzky to its team of Operating Partners.
Kuritzky brings over 15 years of leadership and executive consulting experience in scaling and enhancing the sales and marketing functions for public and privately owned companies.
Working alongside One Rock Operating Partners Brian Potts and Kush Tulsidas, he will be responsible for assessing sales and marketing strategies at target companies and One Rock’s portfolio companies, post-acquisition.
Prior to being engaged by One Rock, Kuritzky served as a Vice President of Sales and then as an Executive Vice President of Sales and Marketing in
Ceros Capital Markets, a division of Ceros Financial Services, announced that it has, has completed a USD17.14 million Series A2 Preferred Stock financing round for Aquyre Biosciences, a US company which has developed and built a disruptive medical diagnostic platform for on-site adequacy assessment of tissue biopsies.
Special Reports
Featured
Events
12 November, 2026 – 8:00 am
12 November, 2026 – 5:00 pm
